Koninklijke Philips N.V. (PHIA) Earnings Call Transcripts

Koninklijke Philips N.V.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Koninklijke Philips N.V. reported a 3.7% increase in comparable sales, driven by strong growth in North America and personal health, despite ongoing macroeconomic challenges. Adjusted EBITDA margin improved by 40 basis points to 9%, reflecting effective cost management and innovation-driven growth. Management reiterated full-year guidance for comparable sales growth of 3% to 4.5%, indicating confidence in maintaining momentum despite geopolitical uncertainties and supply chain pressures.

Reported metrics

Guidance from management

Philips reiterated its full-year guidance for comparable sales growth of 3% to 4.5% and adjusted EBITDA margin guidance of 12.5% to 13%. Management remains focused on cost mitigation strategies amid ongoing inflationary pressures.

What management said

Hello, everyone, and welcome to Philips' First Quarter 2026 Results Webcast. I'm here with our CEO, Roy Jakobs, and our CFO, Charlotte Hanneman. Our results press release and presentation are available on our Investor Relations website. The replay and full transcript of this webcast will be available on our website after this call concludes. I want to draw your attention to our safe harbor statement on the screen and...

And maybe 1 addition. What is also helping it, David, is, we have been expanding our retail distribution. So actually, we have been getting listings and placements in the wet shelf and particularly of big retailers. And that actually we gives us additional sustainable growth opportunity for the quarters to come. So it's the combination of BD grade innovation, but also now having a better access event the consumers th...

What analysts pressed on

Analysts expressed concerns regarding the sustainability of growth in China, particularly in precision diagnostics due to centralized procurement. There were also questions about the impact of cost inflation on margins and how Philips plans to navigate these challenges moving forward.

Main topics on the call

• Order Intake Growth — Philips experienced a 6% increase in order intake, with strong contributions from North America and personal health. CEO Roy Jakobs noted, "Order intake grew 6%, reflecting continued momentum," highlighting the company's...
• Margin Expansion — The adjusted EBITDA margin rose to 9%, up 40 basis points year-over-year, driven by sales growth and productivity measures. CFO Charlotte Hanneman stated, "Adjusted EBITDA margin increased by 40 basis points year-on-year...
• Geopolitical and Supply Chain Challenges — Management acknowledged ongoing geopolitical tensions, particularly in the Middle East, which are expected to impact sales. However, they maintained that these factors would not materially affect the overall group perfor...
• China Market Dynamics — Philips continues to face challenges in China, particularly in precision diagnosis due to centralized procurement pressures. Jakobs mentioned, "China is showing continued cautious development," indicating a cautious outl...

Read the full Koninklijke Philips N.V. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 41 Koninklijke Philips N.V. earnings call transcripts on record, spanning January 28, 2020 to July 28, 2026. Based on this history, Koninklijke Philips N.V. reports quarterly. The most recent call on file is dated July 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

PHIA

Exchange

ENXTAM

Country

NL

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

41

First call

January 28, 2020

Most recent

July 28, 2026

Reporting cadence

quarterly